Oncology Investment Portfolios

Companies
Pasithea Therapeutics' Stock On The Rise Following Promising Trial Data Sep 27, 2024
Companies
Pyxis Oncology Announces Participation in Upcoming Investor Conferences Aug 29, 2024
Companies
Cellectar Biosciences Prepares Key Opinion Leader Event for CLOVER WaM Trial Analysis Jun 28, 2024
Analysis
Clarivate Showcases Seven Key Innovators Shaping the Future of Antibody Drug Conjugates Jun 20, 2024
Companies
Pyxis Oncology Appoints Industry Veteran Michael A. Metzger to Board of Directors Jun 11, 2024
Companies
Pyxis Oncology Discusses Future Therapeutics at the Jefferies Global Healthcare Conference May 30, 2024
Companies
BrightSpring Health and Onco360® Secure National Pharmacy Partnership for OJEMDA™ May 21, 2024
Companies
Kineta, Inc. Announces Participation in H.C. Wainwright Virtual Fireside Chat Feb 7, 2024
Companies
Mainz Biomed Launches European Oncology Lab for Enhanced Cancer Detection in Germany Feb 7, 2024
Pharmaceuticals
Corbus Pharmaceuticals Set to Present Phase 1 Clinical Data of SYS6002 at 2024 ASCO GU Jan 23, 2024
Companies
Strategic Alliance between SOPHiA GENETICS and Karkinos Healthcare to Revolutionize Cancer Research in India Jan 16, 2024
Companies
Kineta Confirms Attendance at the 13th Annual LifeSci Partners Corporate Access Event Jan 4, 2024
Companies
Bristol Myers Squibb Strikes $4 Billion Deal to Acquire Oncology Player RayzeBio Dec 27, 2023
Companies
Precipio, Inc. Reflects on 2023's Milestones and Sets Course for 2024 Dec 15, 2023
Analysis
StockNews.com Begins Coverage on Mirati Therapeutics NASDAQ:MRTX Nov 12, 2023